Inhibitor Therapeutics INTI
OTC INTI
$0.08 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Inhibitor Therapeutics (INTI) Other Non Operating Income (2009 - 2021)

Updated

Inhibitor Therapeutics' Other Non Operating Income was $30,000 in Q2 2013, unchanged from the prior quarter.

Analysis

Inhibitor Therapeutics (INTI) Other Non Operating Income (2009 - 2021) Analysis & Trends

For FY2012, Other Non Operating Income at Inhibitor Therapeutics came in at $666,667.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Inhibitor Therapeutics 13.90 Mn 6.72 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 41,600.00
Jun 30, 2013 30,000.00
Mar 31, 2013 30,000.00
Dec 31, 2012 -119,045.00
Sep 30, 2012 777,756.00
Mar 31, 2012 7,956.00
Jun 30, 2011 434.00
Mar 31, 2011 95,756.00
Dec 31, 2010 -89,470.00
Sep 30, 2010 12,623.00
Jun 30, 2010 66,169.00
Mar 31, 2010 13,327.00
Dec 31, 2009 -185,048.00
Sep 30, 2009 159.00
Jun 30, 2009 170,338.00
Mar 31, 2009 -37,499.00
API Access

Inhibitor Therapeutics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=INTI&period=max&api_key=YOUR_API_KEY